维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

10篇 您的检索式：作者名="Idrees R"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Shellfish allergy and relation to iodinated contrast media: United Kingdom survey显示文摘AIM: To assess current practice of United Kingdom cardiologists with respect to patients with reported shellfish/iodine allergy, and in particular the use of iodinated contrast for elective coronary angiography.Moreover we have reviewed the current evidence-base and guidelines available in this area.METHODS: A questionnaire survey was send to 500senior United Kingdom cardiologists(almost 50% cardiologists registered with British Cardiovascular Society)using email and first 100 responses used to analyze practise. We involved cardiologists performing coronary angiograms routinely both at secondary and tertiary centres. Three specific questions relating to allergy were asked:(1) History of shellfish/iodine allergy in pre-angiography assessment;(2) Treatments offeredfor shellfish/iodine allergy individuals; and(3) Any specific treatment protocol for shellfish/iodine allergy cases. We aimed to establish routine practice in United Kingdom for patients undergoing elective coronary angiography. We also performed comprehensive PubMed search for the available evidence of relationship between shellfish/iodine allergy and contrast media.RESULTS: A total of 100 responses were received, representing 20% of all United Kingdom cardiologists. Ninety-three replies were received from consultant cardiologists, 4 from non-consultant grades and 3 from cardiology specialist nurses. Amongst the respondents, 66% routinely asked about a previous history of shellfish/iodine allergy. Fifty-six percent would pre-treat these patients with steroids and anti-histamines. The other 44% do nothing, or do nonspecific testing based on their personal experience as following:(1) Skin test with 1 mL of subcutaneous contrast before intravenous contrast;(2) Test dose 2 mL contrast before coronary injection;(3) Close observation for shellfish allergy patients; and(4) Minimal evidence that the steroid and anti-histamine regime is effective but it makes us feel better.CONCLUSION: There is no evidence that allergy to shellfish alters the risk of reaction to intravenous contrast more than any other allergy and asking about such allergies in pre-angiogram assessment will not provide any additional information except propagating the myth.	Mudassar Baig Ahmad Farag Jamal Sajid Rahul Potluri R Bruce Irwin Hafiz Mohammed Idrees Khalid	2014	World Journal of Cardiology2014，6，3：	3
	2	Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer显示文摘	Faridi R Zahra A Khan K Idrees M		0，，：	1
	3	Invasive roicropapillary carcino- roa of breast : An under - recognized entity, a series of eight cases 显示文摘	Uddin Z Idrees R Aflab K	2012	Breast J2012，18，3：	1
	4	Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer显示文摘	Cheng YW Idrees K Shattock R		0，，02：	1
	5	Loss of imprint-ing and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer显示文摘	Cheng YW Idrees K Shattock R	2009	Int J Cancer2009，10，2：	1
	6	Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer显示文摘	Cheng YW Idrees K Shattock R	2010	Int J Cancer2010，127，3：	1
	7	Secretory carcinoma of breast clinicopathologic study of 8 cases 显示文摘	Din N U Idrees R Fatima S Kayaui N	2013	Ann Diagn Pathol2013，17，1：	1
	8	Secretory carcinoma of breast:clinicopathologic study of 8 cases显示文摘	Din NU Idrees R Fatima S	2013	Ann Diagn Pathol2013，17，1：	1
	9	Invasive micropapillary carcinoma of breast: An under-recognized entity, A series of eight cases显示文摘	Uddin Z Idrees R Aftab K	2012	The Breast Journal2012，18，3：	1
	10	Oncogenic poten-tial of Human Papillomavirus (HPV) and its relation with cervical cancer显示文摘	Faridi R Zahra A Khan K Idrees M		0，，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费